Key Takeaway
See the average weight loss on Mounjaro broken down by month. Understand the dose titration timeline, what each month looks like, and how to improve your monthly progress.
Mounjaro (tirzepatide) delivers some of the fastest and most substantial monthly weight loss of any GLP-1 medication, with patients losing an average of 4 to 6 pounds per month during the first 6 months and continuing to lose weight through at least 18 months of treatment. Here is exactly what the data shows for each month.
Mounjaro's dual GIP/GLP-1 receptor mechanism produces consistently higher monthly weight loss rates compared to single-receptor GLP-1 medications. Understanding the month-by-month trajectory helps you evaluate your own progress and work with your provider to improve results. how Mounjaro works
Month-by-Month Weight Loss Data
The following table synthesizes data from the SURMOUNT-1 trial[1] (patients with obesity, no diabetes) across all three dose levels. Starting weight in the trial was approximately 231 pounds on average.
| Month | Dose Range | Cumulative Loss (5 mg) | Cumulative Loss (10 mg) | Cumulative Loss (15 mg) |
|---|---|---|---|---|
| 1 | 2.5 mg | 3 to 4 lbs | 3 to 5 lbs | 4 to 6 lbs |
| 2 | 5 mg | 8 to 10 lbs | 9 to 11 lbs | 10 to 13 lbs |
| 3 | 5 to 7.5 mg | 13 to 15 lbs | 15 to 18 lbs | 17 to 20 lbs |
| 4 | 7.5 to 10 mg | 16 to 19 lbs | 20 to 24 lbs | 23 to 27 lbs |
| 6 | 10 to 15 mg | 22 to 25 lbs | 28 to 33 lbs | 33 to 38 lbs |
| 9 | Maintenance | 27 to 30 lbs | 36 to 40 lbs | 40 to 44 lbs |
| 12 | Maintenance | 30 to 33 lbs | 40 to 43 lbs | 44 to 47 lbs |
| 18 (end SURMOUNT-1) | Maintenance | ~35 lbs | ~45 lbs | ~48 lbs |
What Each Month Looks Like in Practice
Month 1: Getting Started (2.5 mg)
The 2.5 mg introductory dose lets your body adjust to tirzepatide's effects. Even at this low dose, most patients experience a noticeable shift in appetite. Meals become more manageable, and between-meal hunger decreases. Weight loss during this first month typically ranges from 3 to 6 pounds. Check out our see real Zepbound results for detailed data.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
Side effects are generally mild. The most common are nausea (affecting about 15% to 20% of patients), decreased appetite, and occasional diarrhea or constipation. These symptoms usually peak during the first week and improve as your body adapts. Mounjaro first month tips
Month 2: Noticeable Appetite Changes (5 mg)
The step up to 5 mg brings stronger appetite suppression. Many patients say this is the month where they truly feel the medication working. Portions shrink naturally, and the urge to snack or eat out of boredom diminishes. Cumulative weight loss reaches roughly 4% to 5% of starting weight.
This is also when patients begin to notice subtle changes in how their clothes fit. The scale may show 8 to 13 pounds lost, depending on the target dose. Blood sugar levels often start improving during this month, particularly for patients with insulin resistance or prediabetes.
Month 3: Visible Progress (7.5 mg)
By month 3, many patients have lost enough weight for the changes to become visible. Faces appear slimmer, waistlines shrink, and rings and watches may feel looser. Cumulative weight loss often reaches 7% to 9% of starting weight on the higher dose tracks.
Energy and mobility improvements are common during this month. Patients who were previously limited in their physical activity often find they can walk farther, climb stairs more easily, and exercise with less discomfort. This creates a positive feedback loop that supports ongoing weight loss. exercise on Mounjaro
Months 4 to 6: Peak Rate Phase (10 to 15 mg)
This period typically produces the fastest monthly weight loss rates. Patients are reaching or have reached their target maintenance dose, and the dual GIP/GLP-1 mechanism is operating at full strength. Monthly losses of 3 to 5 pounds are common during this stretch.
By month 6, cumulative weight loss often reaches 14% to 17% of starting weight on the 15 mg dose. To put that in practical terms, a patient who started at 250 pounds is now around 210 to 215 pounds. That's a substantial visible transformation.
Health markers frequently improve dramatically during this phase. Blood pressure, triglycerides, HbA1c, liver enzymes, and inflammatory markers often show significant positive changes. Many patients are able to reduce or eliminate other medications under their provider's guidance. Mounjaro metabolic improvements
Months 7 to 12: Continued Progress
The rate of monthly weight loss gradually decreases during this period, but weight continues to come off. Monthly losses of 1 to 3 pounds are typical. This deceleration is biologically normal as the body adjusts to a lower weight and the caloric deficit narrows.
By month 12, patients on the 15 mg dose have typically lost 19% to 21% of their starting weight. The 10 mg dose group reaches approximately 17% to 19%, and the 5 mg group reaches approximately 13% to 15%. All three dose levels produce clinically meaningful results.
Months 13 to 18: Extended Results
The SURMOUNT-1 trial ran through 72 weeks (approximately 18 months), and weight loss continued throughout. The final 6 months of the trial added approximately 1% to 2% more weight loss for most patients. While the monthly rate is modest during this phase, the fact that weight continues trending downward rather than rebounding is significant.
How Mounjaro Monthly Weight Loss Compares
| Medication | Avg Monthly Loss (Months 2-6) | Avg Monthly Loss (Months 7-12) | Total at 12 Months |
|---|---|---|---|
| Mounjaro 15 mg | 4 to 6 lbs | 1 to 3 lbs | 44 to 47 lbs |
| Wegovy 2.4 mg | 3 to 5 lbs | 1 to 2 lbs | 33 to 35 lbs |
| Ozempic 1.0 mg | 2 to 4 lbs | 1 to 2 lbs | 20 to 28 lbs |
Mounjaro vs Wegovy vs Ozempic
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Maximizing Each Month
Protein at every meal. As your total caloric intake drops, making sure protein makes up a larger share of your diet helps preserve muscle mass and keeps you feeling satisfied between meals. Aim for 80 to 120 grams daily. nutrition guide for Mounjaro patients
Stay hydrated. Dehydration is one of the most under-recognized issues for patients on GLP-1 medications. When you eat less, you also consume less water from food. Aim for at least 64 to 80 ounces of fluids daily.
Build exercise gradually. Start where you're comfortable and add intensity over time. Walking is an excellent foundation. As your weight decreases and your energy improves, consider adding swimming, cycling, or resistance training to further enhance your results.
Manage expectations during plateaus. Nearly every patient experiences at least one plateau during their Mounjaro treatment. A plateau lasting 2 to 4 weeks is normal. If it extends beyond 6 weeks, work with your provider to explore potential adjustments.
Frequently Asked Questions
How much weight will I lose in the first 3 months on Mounjaro?
Most patients lose 7% to 9% of their body weight in the first 3 months, which translates to approximately 15 to 20 pounds for someone starting at 230 pounds. Patients on the higher dose tracks tend to lose slightly more during this period.
Does weight loss slow down after month 6 on Mounjaro?
The rate of loss does decrease after month 6, which is a normal physiological response. But weight continues to decrease through at least 18 months of treatment. Think of it as a gradual transition from active weight loss to weight stabilization at a much lower level.
Is losing 5 pounds per month on Mounjaro a good result?
Five pounds per month is an excellent rate of weight loss that's sustainable and healthy. Over 12 months, that pace would total 60 pounds, which exceeds the clinical trial average. Not every month will produce exactly 5 pounds, but averaging near that rate indicates strong response to treatment.
Why did I lose more weight in month 2 than month 5?
This pattern is common and normal. Early weight loss includes some water weight and initial metabolic response, which can produce higher numbers in the first few months. As your body adjusts to a lower weight, the monthly rate naturally moderates. The overall trajectory is what matters most.
Medical References
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
Get Expert Monthly Monitoring with FormBlends
FormBlends provides physician-supervised Mounjaro and tirzepatide treatment with monthly progress reviews. Our telehealth platform lets you connect with your care team, review your monthly weight loss trajectory, and make data-driven adjustments to your treatment plan. get started with FormBlends
Start your consultation today and begin your Mounjaro process with clinical guidance every step of the way.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →